Skip to Main Content

Paper Details

Informed Consent among Clinical Trial Participants with Different Cancer Diagnoses.
AJOB Empir Bioeth
0
2023
Cancer, Participants, breast or gynecological cancer, cancer, gastro-intestinal or genitourinary, hematologic-lymphatic malignancies, lung cancer, participant, participants, patient, patients, physicians
Author NameAffiliation
Connie M UlrichUniversity of Pennsylvania School of Nursing
Connie M UlrichUniversity of Pennsylvania Perelman School of Medicine
Sarah J Ratcliffe (CM4AI)University of Virginia
Camille J HochheimerUniversity of Virginia
Qiuping ZhouGeorge Washington University
Liming HuangUniversity of Pennsylvania School of Nursing
Thomas GordonUniversity of Massachusetts Lowell
Kathleen A KnaflUniversity of North Carolina at Chapel Hill
Therese RichmondUniversity of Pennsylvania School of Nursing
Marilyn M SchapiraUniversity of Pennsylvania Perelman School of Medicine
Victoria MillerChildren's Hospital of Philadelphia
Jun J MaoMemorial Sloan Kettering Cancer Center
Mary NaylorUniversity of Pennsylvania School of Nursing
Christine GradyNational Institutes of Health, Clinical Center Department of Bioethics
  • 1 - 14

Datasets

Release 1.2